Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2001, for Anthem, Inc. (formerly Anthem Insurance Companies, Inc.). The filing details the company's operations as a major health benefits provider and independent licensee of the Blue Cross Blue Shield Association. A pivotal event occurred shortly after the reporting period: on November 2, 2001, the company completed its demutualization, converting from a mutual insurance company to a stock insurance company and conducting an Initial Public Offering (IPO) and an Equity Security Units offering.
Key Financial Metrics
| Metric (Nine Months Ended Sep 30, 2001) | Value ($ Millions) | Prior Period (2000) |
|---|---|---|
| Total Operating Revenue | $7,525.9 | $6,225.9 |
| Net Income | $254.5 | $153.8 |
| Operating Gain | $212.4 | $119.9 |
| Benefit Expense Ratio | 85.2% | 85.7% |
| Operating Margin | 2.8% | 1.9% |
| Cash from Operating Activities | $511.8 | $483.0 |
| Total Assets | $6,093.2 | $5,708.5 |
| Policyholders' Surplus | $2,174.9 | $1,919.8 |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenue increased 21% ($1,300.0 million) driven by a 22% increase in premiums and a 13% increase in administrative fees. Growth was fueled by premium rate increases, higher membership (up 10% to 7.8 million), and the acquisition of Blue Cross and Blue Shield of Maine (BCBS-ME).
- Profitability Surge: Net income rose 65% ($100.7 million). This was significantly aided by a $61.2 million increase in net realized gains on investments (due to portfolio restructuring) and a $25.0 million gain from the sale of the TRICARE subsidiary operations.
- Expense Management: The benefit expense ratio improved by 50 basis points to 85.2%, and the administrative expense ratio (including premium equivalents) improved by 60 basis points to 14.1%, reflecting operational efficiency and the divestiture of the lower-margin TRICARE business.
- Investment Portfolio: The company restructured its equity portfolio into fixed maturity securities and equity index funds, resulting in significant realized gains in the third quarter.
Guidance, Outlook, and Risks
- Demutualization and Capital Raise: The company completed an IPO raising approximately $1.99 billion and a Units offering raising $230 million. Proceeds were primarily used to pay eligible statutory members cash in lieu of shares ($2.06 billion) and cover transaction costs. The company expects to use remaining funds for general corporate purposes and the pending acquisition of Blue Cross and Blue Shield of Kansas.
- Strategic Exits: The company withdrew from the Medicare+Choice program in Connecticut (Jan 2001) and announced an intent to withdraw from the Colorado Medicare+Choice market effective Jan 1, 2002, due to poor results in those specific markets.
- Liquidity: The company maintains strong liquidity with $364.6 million in cash and cash equivalents. It established two new unsecured revolving credit facilities totaling $800 million in November 2001.
- Legal and Regulatory Risks:
- Litigation: The company faces multiple class-action lawsuits in Connecticut regarding ERISA violations and provider payments. A significant wrongful death/bad faith case in Ohio (Dardinger) is pending before the Supreme Court of Ohio, with a potential punitive damages award of $49 million under review.
- Government Audits: Ongoing reviews by the Office of Inspector General (OIG) regarding Medicare fiscal intermediary operations and the Federal Employee Program (FEP) could result in fines or penalties, though management does not currently anticipate a material adverse effect.
- TRICARE Guarantee: The company retains a guarantee on the TRICARE contract sold to Humana, capped at $20 million annually and $75 million cumulatively, though no call on the guarantee is anticipated for open periods.
Investor Verification Checklist
- Demutualization Accounting: Verify the pro forma financial impact of the demutualization and the specific allocation of IPO proceeds to statutory members versus retained capital.
- Investment Gains Sustainability: Assess the sustainability of the $61.2 million net realized gain, which was largely driven by a one-time portfolio restructuring rather than organic investment income growth.
- Reserve Adequacy: Review the $21.0 million in reserve strengthening recorded in the Midwest and East regions to ensure future claims liabilities are adequately covered.
- Legal Exposure: Monitor the outcome of the Ohio Supreme Court appeal regarding the Dardinger punitive damages and the status of the Connecticut ERISA class actions.
- Medicare+Choice Strategy: Evaluate the financial impact of exiting the Medicare+Choice markets in Connecticut and Colorado on future revenue streams.